“…Pyripyropenes are meroterpenoids first isolated from Aspergillus fumigatus by the Ōmura group [ 17 ]. To date, only 25 pyripyropenes bearing different substitution (hydroxyl, acetoxyl, or propionyloxy groups) at C-1, C-7, C-11 and C-13 of the terpenoid moiety have been obtained from natural sources, with pyripyropenes A–R from A. fumigatus FO-1289 and its mutant [ 17 , 32 , 33 ], pyripyropenes S–T from A. similanensis [ 34 , 35 ], 1-deacetylpyripyropene A, 11-deacetylpyripyropene O and 13-dehydroxy-1,11-deacetylpyripyropene A from Fusarium lateritium [ 36 ], 7-deacetylpyripyropene A ( 3 ) and 13-dehydroxylpyripyropene A from N. pseudofischeri [ 16 ]. Pyripyropenes, in particular pyripyropene A ( 4 ), were discovered as a highly potent selective inhibitor of the ACAT-2 isoform, which was considered a new therapeutic target for the treatment and prevention of hypercholesterolemia and atherosclerosis [ 14 ].…”